qdenga
takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - dengue - vacciner - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.
suvaxyn m. hyo - parasuis vet. injektionsvæske, suspension
zoetis finland oy - haemophilus parasuis serotype 4, haemophilus parasuis serotype 5, stamme 4800, helcellekoncentrat (inaktiveret), mycoplasma hyopneumoniae, stamme p-5722-3 (inaktiveret) - injektionsvæske, suspension - svin
aftovaxpur doe
boehringer ingelheim vetmedica gmbh - højst tre af følgende renset, inaktiveret, mund-og klovesyge virus-stammer: o1 manisa ≥ 6 pd50*; o1 bfs ≥ 6 pd50*; o taiwan 3/97 ≥ 6 pd50*; a22 irak ≥ 6 pd50*; a24 cruzeiro ≥ 6 pd50*; en kalkun 14/98 ≥ 6 pd50*; asien 1 shamir ≥ 6 pd50*; sat2 saudi-arabien ≥ 6 pd50*; * pd50 – 50% beskyttende dosis i kvæg, som er beskrevet i ph. eur. monografi 0063. - immunologiske - pigs; cattle; sheep - aktiv immunisering af kvæg, får og svin fra 2 uger mod mund- og klovesyge for at reducere kliniske tegn.
suivac app2 injektionsvæske, emulsion
chemvet dk a/s - actinobacillus pleuropneumoniae toxoid type 2, apxii, (105 kd), actinobacillus pleuropneumoniae toxoid type 3, apxiii, (120 kd), actinobacillus pleuropneumoniae, serotype 2, stamme app2tr98, inaktiveret - injektionsvæske, emulsion
hyobac app multi vet. injektionsvæske, emulsion
salfarm danmark a/s - actinobacillus pleuropneumoniae serotype 5 strain wslb 3079, actinobacillus pleuropneumoniae serotype 6 strain wslb 3075, actinobacillus pleuropneumoniae toxoid type 1, apxi, (105 kd), actinobacillus pleuropneumoniae toxoid type 2, apxii, (105 kd), actinobacillus pleuropneumoniae toxoid type 3, apxiii, (120 kd), actinobacillus pleuropneumoniae, serovar 2, stamme wslb 3012 - injektionsvæske, emulsion - svin
erybac uno vet. injektionsvæske, emulsion
salfarm danmark a/s - erysipelothrix rhusiopathiae, inaktiveret (serotype 2: e.r.-2-64; -2-5; -2-ii, serotype 1: -1-203) - injektionsvæske, emulsion - svin
hyobac app6 vet. injektionsvæske, emulsion
salfarm danmark a/s - actinobacillus pleuropneumoniae apx ii toxoid, stamme wslb 3075, actinobacillus pleuropneumoniae apx iii toxoid, stamme wslb 3075, actinobacillus pleuropneumoniae serotype 6 strain wslb 3075 - injektionsvæske, emulsion - svin
bovigen rce vet. injektionsvæske, emulsion
forte healthcare limited - bovin coronavirus, stamme c-197 (inaktiveret), bovin rotavirus, stamme tm-91, serotype g6p1 (inaktiveret), escherichia coli bakterie, stamme ec/17, expressing f5 (k99) adhesin (inaktiveret) - injektionsvæske, emulsion
syvagen ery injektionsvæske, emulsion
boehringer ingelheim vetmedica gmbh - erysipelothrix rhusiopathiae serotype 2 (inaktiveret) - injektionsvæske, emulsion
adjupanrix (previously pandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals)
glaxosmithkline biologicals s.a. - splittet influenzavirus, inaktiveret, indeholdende antigen: a / vietnam / 1194/2004 (h5n1) som brugt belastning (nibrg-14) - influenza, human; immunization; disease outbreaks - vacciner - prophylax af influenza i en officielt erklæret pandemisk situation. pandemic influenza vaccine bør anvendes i overensstemmelse med officielle retningslinjer.